Panamerican Journal of Trauma, Critical Care & Emergency Surgery

Register      Login

VOLUME 11 , ISSUE 1 ( January-April, 2022 ) > List of Articles

Perspectives

Rebound Intracranial Hypertension during Fluid Therapy in Neurointensive Care: A Proposal for Scheduled Discontinuation

Tariq M Janjua, Luis R Moscote-Salazar

Keywords : Keywords: Critical care, Fluid therapy, Neurointensive care, Traumatic brain injury

Citation Information : Janjua TM, Moscote-Salazar LR. Rebound Intracranial Hypertension during Fluid Therapy in Neurointensive Care: A Proposal for Scheduled Discontinuation. Panam J Trauma Crit Care Emerg Surg 2022; 11 (1):59-60.

DOI: 10.5005/jp-journals-10030-1369

License: CC BY-NC 4.0

Published Online: 24-05-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

The fluid administration for intensive care of critically ill patients is one of the pillars in intensive care medicine. The rational use of fluid therapy must include adequate knowledge of the pharmacological aspects of these agents whose characteristics frame the concept of fluid therapy. The same holds for neurological crisis patients that the fluid therapy strategies aim to guarantee requirements to maintain oxygenation and cerebral blood flow in physiological constants.


PDF Share
  1. Vincent JL. Fluid management in the critically ill. Kidney Int 2019;96(1):52–57. DOI: 10.1016/j.kint.2018.11.047. Epub 2019. PMID: 30926137.
  2. Finfer S, Myburgh J, Bellomo R. Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol 2018;14(9):541–557. DOI:10.1038/s41581-018-0044-0
  3. van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care 2016;20(1):126. DOI: 10.1186/s13054-016-1309-2
  4. Chesnut RM, Temkin N, Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med 2012;367(26): 2471–2481. DOI: 10.1056/NEJMoa1207363. Epub 2012.
  5. Nau R. Osmotherapy for elevated intracranial pressure: a critical reappraisal. Clin Pharmacokinet 2000;38(1):23–40. DOI: 10.2165/00003088-200038010-00002
  6. Kofke WA. Mannitol: potential for rebound intracranial hypertension? J Neurosurg Anesthesiol 1993;5(1):1–3. DOI: 10.1097/00008506-199301000-00001. PMID: 8431664.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.